AbbVie
ABBV
ABBV
3,478 hedge funds and large institutions have $249B invested in AbbVie in 2024 Q3 according to their latest regulatory filings, with 241 funds opening new positions, 1,416 increasing their positions, 1,387 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 3,346 → 3,478 (+132)
2% more repeat investments, than reductions
Existing positions increased: 1,416 | Existing positions reduced: 1,387
0.21% more ownership
Funds ownership: 71.57% → 71.78% (+0.21%)
Holders
3,478
Holding in Top 10
208
Calls
$3.65B
Puts
$2.87B
Top Buyers
| 1 | +$1.02B | |
| 2 | +$411M | |
| 3 | +$291M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$250M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$195M |
Top Sellers
| 1 | -$409M | |
| 2 | -$358M | |
| 3 | -$277M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$260M |
| 5 |
APG Asset Management
Amsterdam,
Netherlands
|
-$250M |